UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 47

Sortiert nach

Treatment duration of febrile urinary tract infection: a pragmatic randomized, double-blind, placebo-controlled non-inferiority trial in men and women

BMC medicine, 2017-04, Vol.15 (1), p.70-70, Article 70

2017

Volltextzugriff (PDF)

Procalcitonin reflects bacteremia and bacterial load in urosepsis syndrome: a prospective observational study

Critical care (London, England), 2010-01, Vol.14 (6), p.R206-R206

2010

Volltextzugriff (PDF)

Procalcitonin, mid-regional proadrenomedullin and C-reactive protein in predicting treatment outcome in community-acquired febrile urinary tract infection

BMC infectious diseases, 2019-02, Vol.19 (1), p.161-10, Article 161

2019

Volltextzugriff (PDF)

Hospitalization for community-acquired febrile urinary tract infection: validation and impact assessment of a clinical prediction rule

BMC infectious diseases, 2017-06, Vol.17 (1), p.400-400, Article 400

2017

Volltextzugriff (PDF)

A mycotic aneurysm of the abdominal aorta caused by Mycobacterium bovis after intravesical instillation with bacillus Calmette-Guérin

Journal of vascular surgery cases and innovative techniques, 2018-06, Vol.4 (2), p.122-125

2018

Volltextzugriff (PDF)

Hyperhomocysteinemia as a Risk Factor for Deep-Vein Thrombosis

The New England journal of medicine, 1996-03, Vol.334 (12), p.759-762

1996

Volltextzugriff (PDF)

Ruling out Pulmonary Embolism in Patients with (Suspected) COVID-19—A Prospective Cohort Study

TH open : companion journal to thrombosis and haemostasis, 2021-07, Vol.5 (3), p.e387-e399

2021

Volltextzugriff (PDF)

PCSK9 inhibition with evolocumab (AMG 145) in heterozygous familial hypercholesterolaemia (RUTHERFORD-2): a randomised, double-blind, placebo-controlled trial

The Lancet (British edition), 2015-01, Vol.385 (9965), p.331-340

2015

Volltextzugriff (PDF)

Coronavirus disease 2019 and peripheral blood eosinophil counts: a retrospective study

Infection, 2021-12, Vol.49 (6), p.1325-1329

2021

Volltextzugriff (PDF)

Treatment duration of febrile urinary tract infection (FUTIRST trial): a randomized placebo-controlled multicenter trial comparing short (7 days) antibiotic treatment with conventional treatment (14 days)

BMC infectious diseases, 2009-08, Vol.9 (1), p.131-131, Article 131

2009

Volltextzugriff (PDF)

Thrombophilia, clinical factors, and recurrent venous thrombotic events

JAMA : the journal of the American Medical Association, 2005-05, Vol.293 (19), p.2352

2005

Volltextzugriff (PDF)

Hemostatic effects of oral contraceptives in women who developed deep-vein thrombosis while using oral contraceptives

Thrombosis and haemostasis, 1998-09, Vol.80 (3), p.382

1998

Volltextzugriff (PDF)

John Hageman's factor and deep‐vein thrombosis: Leiden Thrombophilia Study

British journal of haematology, 1994-06, Vol.87 (2), p.422-424

1994

Volltextzugriff (PDF)

Risk factors for fluoroquinolone-resistant Escherichia coli in adults with community-onset febrile urinary tract infection

Journal of antimicrobial chemotherapy, 2011-03, Vol.66 (3), p.650-656

2011

Volltextzugriff (PDF)

Biomarker guided triage can reduce hospitalization rate in community acquired febrile urinary tract infection

The Journal of infection, 2018-07, Vol.77 (1), p.18-24

2018

Volltextzugriff (PDF)

Glycogen storage disease type Ia: Adult presentation with microcytic anemia and liver adenomas

Hepatology (Baltimore, Md.), 2018-08, Vol.68 (2), p.780-782

2018

Volltextzugriff (PDF)

Role of clotting factor VIII in effect of von Willebrand factor on occurrence of deep-vein thrombosis

The Lancet (British edition), 1995-01, Vol.345 (8943), p.152-155

1995

Volltextzugriff (PDF)

Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study

The Lancet (British edition), 1993-12, Vol.342 (8886), p.1503-1506

1993

Volltextzugriff (PDF)

Increased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Leiden mutation

The Lancet (British edition), 1994-11, Vol.344 (8935), p.1453-1457

1994

Volltextzugriff (PDF)

Mutation in blood coagulation factor V associated with resistance to activated protein C

Nature (London), 1994-05, Vol.369 (6475), p.64-67

1994

Volltextzugriff (PDF)

Diabetes and the course of febrile urinary tract infection

Diabetes care, 2013-12, Vol.36 (12), p.e193-e194

2013

Volltextzugriff (PDF)

Conclusions

Journal of vascular surgery cases and innovative techniques, 2018, Vol.4 (2), p.122-125

2018

Volltextzugriff (PDF)

Protein C Deficiency in a Controlled Series of Unselected Outpatients: An Infrequent But Clear Risk Factor for Venous Thrombosis (Leiden Thrombophilia Study)

Blood, 1995-05, Vol.85 (10), p.2756-2761

1995

Volltextzugriff (PDF)

High factor VIII antigen levels increase the risk of venous thrombosis but are not associated with polymorphisms in the von Willebrand factor and factor VIII gene

British journal of haematology, 2001-10, Vol.115 (1), p.156-158

2001

Volltextzugriff (PDF)

Out of Hospital Treatment of Acute Pulmonary Embolism in Patients with a Low NT-ProBNP Level

Blood, 2009-11, Vol.114 (22), p.3996-3996

2009

Volltextzugriff (PDF)

1 – 25 von 47

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(41)
Mit Volltextzugriff
(37)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(30)
Humans
(29)
Life Sciences & Biomedicine
(28)
Female
(25)
Male
(21)
Adult
(17)
Middle Aged
(17)
Aged
(15)
Biological And Medical Sciences
(14)
Medical Sciences
(14)
Risk Factors
(13)
Case-Control Studies
(10)
General & Internal Medicine
(10)
Blood And Lymphatic Vessels
(9)
Cardiology. Vascular System
(9)
Diseases Of The Peripheral Vessels. Diseases Of The Vena Cava. Miscellaneous
(9)
Medicine, General & Internal
(9)
Infectious Diseases
(8)
Adolescent
(7)
Medical Research
(7)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Treatment duration of febrile urinary tract infection: a pragmatic randomized, double-blind, placebo-controlled non-inferiority trial in men and women

Procalcitonin reflects bacteremia and bacterial load in urosepsis syndrome: a prospective observational study

Procalcitonin, mid-regional proadrenomedullin and C-reactive protein in predicting treatment outcome in community-acquired febrile urinary tract infection

Hospitalization for community-acquired febrile urinary tract infection: validation and impact assessment of a clinical prediction rule

A mycotic aneurysm of the abdominal aorta caused by Mycobacterium bovis after intravesical instillation with bacillus Calmette-Guérin

Hyperhomocysteinemia as a Risk Factor for Deep-Vein Thrombosis

Ruling out Pulmonary Embolism in Patients with (Suspected) COVID-19—A Prospective Cohort Study

PCSK9 inhibition with evolocumab (AMG 145) in heterozygous familial hypercholesterolaemia (RUTHERFORD-2): a randomised, double-blind, placebo-controlled trial

Coronavirus disease 2019 and peripheral blood eosinophil counts: a retrospective study

Treatment duration of febrile urinary tract infection (FUTIRST trial): a randomized placebo-controlled multicenter trial comparing short (7 days) antibiotic treatment with conventional treatment (14 days)

Thrombophilia, clinical factors, and recurrent venous thrombotic events

Hemostatic effects of oral contraceptives in women who developed deep-vein thrombosis while using oral contraceptives

John Hageman's factor and deep‐vein thrombosis: Leiden Thrombophilia Study

Risk factors for fluoroquinolone-resistant Escherichia coli in adults with community-onset febrile urinary tract infection

Biomarker guided triage can reduce hospitalization rate in community acquired febrile urinary tract infection

Glycogen storage disease type Ia: Adult presentation with microcytic anemia and liver adenomas

Role of clotting factor VIII in effect of von Willebrand factor on occurrence of deep-vein thrombosis

Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study

Increased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Leiden mutation

Mutation in blood coagulation factor V associated with resistance to activated protein C

Diabetes and the course of febrile urinary tract infection

Conclusions

Protein C Deficiency in a Controlled Series of Unselected Outpatients: An Infrequent But Clear Risk Factor for Venous Thrombosis (Leiden Thrombophilia Study)

High factor VIII antigen levels increase the risk of venous thrombosis but are not associated with polymorphisms in the von Willebrand factor and factor VIII gene

Out of Hospital Treatment of Acute Pulmonary Embolism in Patients with a Low NT-ProBNP Level

Suchergebnisse filtern